Mariner
PRCT icon

Mariner’s Procept Biorobotics PRCT Stock Holding History

Mariner’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$511K Buy
20,415
+1,692
+9% +$47.7K ﹤0.01% 2476
2025
Q4 		$589K Buy
18,723
+2,177
+13% +$72.2K ﹤0.01% 2339
2025
Q3 		$591K Buy
16,546
+1,251
+8% +$57.1K ﹤0.01% 2297
2025
Q2 		$881K Buy
15,295
+2,539
+20% +$144K ﹤0.01% 1891
2025
Q1 		$743K Buy
12,756
+4,350
+52% +$297K ﹤0.01% 1891
2024
Q4 		$677K Buy
8,406
+2,429
+41% +$208K ﹤0.01% 1938
2024
Q3 		$479K Buy
+5,977
New +$425K ﹤0.01% 2156

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mariner's PRCT Position: Q1 2026 in Review

Mariner increased its Procept Biorobotics (PRCT) stake by 9% in Q1 2026, buying an estimated $47.7K and bringing the position to 20,415 shares worth $511K. The position accounts for ﹤0.01% of the portfolio, ranked #2476.

Mariner first reported a position in PRCT in Q3 2024 and has held it in 7 quarters since. The position peaked at $881K in Q2 2025. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Mariner held 20,415 shares of Procept Biorobotics worth $511K as of Q1 2026.
  • Mariner bought 1,692 Procept Biorobotics shares in Q1 2026, an estimated $47.7K.
  • Procept Biorobotics made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #2476 holding.
  • Mariner first reported a position in Procept Biorobotics in Q3 2024 and has held it in 7 quarters since.
  • Mariner's Procept Biorobotics position peaked at $881K in Q2 2025.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.